Skorpios Trust Stoke Therapeutics, Inc. Transaction History
Skorpios Trust
- $76.3 Million
- Q4 2024
A detailed history of Skorpios Trust transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Skorpios Trust holds 6,906,181 shares of STOK stock, worth $60.4 Million. This represents 99.8% of its overall portfolio holdings.
Number of Shares
6,906,181
Previous 8,906,181
22.46%
Holding current value
$60.4 Million
Previous $109 Million
30.41%
% of portfolio
99.8%
Previous 99.85%
Shares
4 transactions
Others Institutions Holding STOK
# of Institutions
136Shares Held
57.3MCall Options Held
5.7KPut Options Held
24.4K-
Black Rock Inc. New York, NY5.41MShares$47.3 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.19MShares$45.3 Million22.22% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$44.8 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$40.5 Million0.57% of portfolio
-
Redmile Group, LLC San Francisco, CA4.59MShares$40.1 Million3.96% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $345M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...